Seeking Alpha

TFF Pharmaceuticals to Participate in the 36th Annual Roth Conference – March 17-19, 2024

A replay of the presentation will be available through the registration link for 90 days. Please contact your Roth representative to schedule one-on-one meetings with the management team during the ...
Business Wire

TFF Pharmaceuticals to Hold Fourth Quarter and Full-Year 2020 Financial Results and Business Results Conference Call on March 10, 2021

AUSTIN, Texas--(BUSINESS WIRE)--TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its ...
Seeking Alpha

TFF Pharmaceuticals Awarded $2.97 Million to Develop Universal Influenza Vaccine

FORT WORTH, Texas, June 26, 2023 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (TFFP) (“the Company”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative ...
Nasdaq

TFF Pharmaceuticals and Leidos to Advance Next-Generation Biodefense Countermeasures Under the DARPA PPB Program into Preclinical Testing

The candidate MCMs delivered by Leidos to TFF Pharmaceuticals have been successfully formulated utilizing the Company’s proprietary Thin Film Freezing technology platform. Formulated materials have ...